New Mountain Capital Terminates Talks with TCP-ASC, R1 RCM Stock Falls
ByAinvest
Monday, Jul 1, 2024 11:02 pm ET1min read
ASC--
R1 RCM (NASDAQ:RCM) shares experienced a significant decline of 9.2% in after-hours trading on March 19, following the announcement that New Mountain Capital had failed to reach an agreement with TCP-ASC on a potential acquisition [1]. Although discussions had been ongoing, no agreement was reached, causing a ripple effect in the financial markets.
New Mountain Capital, a private equity firm owning 32.4% of R1 RCM, and TCP-ASC, an investment vehicle jointly owned by TowerBrook Capital Partners and Ascension Health Alliance, had been considering a potential cash offer of $13.75 per share for all R1's outstanding stock [1]. However, the proposed deal was conditional on a waiver of a standstill agreement, which was not granted.
R1 RCM, in response to the ongoing discussions, formed a special committee of independent directors to evaluate strategic alternatives and directed that any talks between New Mountain Capital and TCP-ASC concerning a potential transaction cease [1]. The company has not approved any of the standstill waivers requested by the shareholders and emphasized that no assurances can be given regarding the outcome or timing of the special committee's review process [1].
This announcement marks a setback for R1 RCM shareholders, who had been anticipating a potential buyout offer. The sudden decline in share price highlights the importance of ongoing negotiations and the potential risks associated with takeover talks.
Sources:
[1] R1 RCM tells shareholders to cease buyout discussions. Becker's Hospital Review. March 11, 2023. https://www.beckershospitalreview.com/finance/r1-rcm-tells-shareholders-to-cease-buyout-discussions.html
NMFC--
RCM--
R1 RCM (NASDAQ:RCM) shares fell 9.2% in after-hours trading after New Mountain Capital announced it failed to reach an agreement with TCP-ASC on a joint proposal for a potential acquisition. Despite ongoing discussions, no agreement was reached. New Mountain had previously sought a waiver to make a takeover offer, proposing a bid of $13.25 per share, down from $13.75. The deal, which also included TowerBrook Capital Partners and Ascension Health as equity co-investors, was conditional on a waiver of a standstill agreement.
R1 RCM (NASDAQ:RCM) shares experienced a significant decline of 9.2% in after-hours trading on March 19, following the announcement that New Mountain Capital had failed to reach an agreement with TCP-ASC on a potential acquisition [1]. Although discussions had been ongoing, no agreement was reached, causing a ripple effect in the financial markets.
New Mountain Capital, a private equity firm owning 32.4% of R1 RCM, and TCP-ASC, an investment vehicle jointly owned by TowerBrook Capital Partners and Ascension Health Alliance, had been considering a potential cash offer of $13.75 per share for all R1's outstanding stock [1]. However, the proposed deal was conditional on a waiver of a standstill agreement, which was not granted.
R1 RCM, in response to the ongoing discussions, formed a special committee of independent directors to evaluate strategic alternatives and directed that any talks between New Mountain Capital and TCP-ASC concerning a potential transaction cease [1]. The company has not approved any of the standstill waivers requested by the shareholders and emphasized that no assurances can be given regarding the outcome or timing of the special committee's review process [1].
This announcement marks a setback for R1 RCM shareholders, who had been anticipating a potential buyout offer. The sudden decline in share price highlights the importance of ongoing negotiations and the potential risks associated with takeover talks.
Sources:
[1] R1 RCM tells shareholders to cease buyout discussions. Becker's Hospital Review. March 11, 2023. https://www.beckershospitalreview.com/finance/r1-rcm-tells-shareholders-to-cease-buyout-discussions.html

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet